MacroGenics, Inc.MGNXNASDAQ
Loading
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +65.39% | +44.90% | +105.99% | -34.21% | +132.53% |
| Gross Profit Growth | +0.00% | +11.51% | +67.23% | -12.94% | +110.22% |
| EBITDA Growth | +0.00% | +0.00% | +0.00% | -60.82% | +0.00% |
| Operating Income Growth | +0.00% | +0.00% | +0.00% | -65.61% | +0.00% |
| Net Income Growth | +0.00% | +0.00% | +0.00% | -70.13% | +0.00% |
| EPS Growth | +0.00% | +0.00% | +0.00% | -70.00% | +0.00% |
| EPS Diluted Growth | +0.00% | +0.00% | +0.00% | -70.00% | +0.00% |
| Weighted Average Shares Growth | +0.89% | +1.08% | +0.75% | +0.78% | +0.85% |
| Weighted Average Shares Diluted Growth | +0.89% | +1.08% | +0.75% | +0.66% | +0.85% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +0.00% | +0.00% | +0.00% | -150.17% | +0.00% |
| Free Cash Flow Growth | +0.00% | +0.00% | +0.00% | -151.39% | +0.00% |
| Receivables Growth | -58.44% | +46.05% | +102.42% | +691.20% | +210.35% |
| Inventory Growth | -100.00% | +655.29% | +731.84% | +169.73% | +0.00% |
| Asset Growth | -12.32% | -9.55% | +22.01% | +2.37% | -1.84% |
| Book Value per Share Growth | -24.62% | -26.27% | -19.98% | -44.63% | -52.51% |
| Debt Growth | +10.27% | +10.16% | +215.67% | +8.53% | +185.00% |
| R&D Expense Growth | -17.87% | -13.75% | -21.15% | -19.32% | -12.64% |
| SG&A Expenses Growth | +0.00% | -27.13% | -35.51% | +0.00% | -66.79% |